Ads
related to: conference calls readers share
Search results
Earnings call: Foot Locker meets market expectations despite a 1.8% decrease in sales By...
Investing.com· 1 day agoFoot Locker , Inc. (NYSE:FL) reported a steady first quarter, with non-GAAP earnings per share (EPS)...
Earnings call: Costco reports solid Q3 growth with strategic expansions By Investing.com
Investing.com· 10 hours agoCostco Wholesale Corporation (NASDAQ:COST) showcased robust financial results for the third quarter...
Is Armie Hammer a Cannibal? House of Hammer Documentary Examined Controversy
COMINGSOON.net via Yahoo News· 2 days agoDisclaimer: This article contains mentions of cannibalism, rape, and abuse. Reader discretion is...
Earnings call: Nordstrom reaffirms annual guidance amid Q1 challenges By Investing.com
Investing.com· 10 hours agoEarnings call: Nordstrom reaffirms annual guidance amid Q1 challenges
Earnings call: Agilent reports mixed Q2 results, plans share repurchase By Investing.com
Investing.com· 1 day agoAgilent Technologies, Inc. (NYSE: NYSE:A), a global leader in life sciences, diagnostics, and...
Earnings call: National Bank of Canada reports a significant increase in earnings per share By...
Investing.com· 1 day agoNational Bank of Canada (OTC:NTIOF) (NBC) has reported a robust financial performance for the second...
Earnings call: Build-A-Bear Workshop faces revenue dip, stays optimistic By Investing.com
Investing.com· 10 hours agoThe company cited lower web demand and a calendar shift as the primary reasons for the decline....
Earnings call: Cracker Barrel reports Q3 revenue, focuses on transformation By Investing.com
Investing.com· 10 hours agoCracker Barrel (NASDAQ:CBRL) Old Country Store, Inc. (CBRL) reported a total revenue of $817.1...
Earnings call: Marvell Technology surpasses Q1 expectations with strong data center demand By...
Investing.com· 10 hours agoThe company's data center revenue saw an impressive 87% year-over-year growth, largely driven by...
Earnings call: Cellectis reports an additional investment of $140 million from AstraZeneca By...
Investing.com· 1 day agoIn their first quarter 2024 earnings call, Cellectis, a biopharmaceutical company, presented a...